RxDoctor Payments Data

Sara Grant, PA

Medical · Raleigh, NCNPI 1710591516

Payments from drug & device makers

$2,333in general payments, 2019–2025

Across 149 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$768
  • Pfizer$336
  • Novo Nordisk$279
  • GSK$172
  • Lilly USA, LLC$159
  • Amgen$121
  • plus $498 from 15 others

What the payments were for

  • Food & beverage$2,333100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,333 in reported general payments places this provider in the 75th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$54,080
Medicare patients
307
Services billed
735

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$14,541
EliquisApixaban12$14,505
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$11,657
Atorvastatin Calcium132$1,699
Omeprazole61$1,213
Venlafaxine Hcl ErVenlafaxine Hcl19$1,172
Losartan Potassium98$1,080
Rosuvastatin Calcium80$1,064
Amlodipine Besylate105$940
Omega-3 Acid Ethyl Esters11$931
Lisinopril91$913
Levothyroxine Sodium89$838
Gabapentin35$754
Carvedilol39$740
Albuterol Sulfate HfaAlbuterol Sulfate26$698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$159$14,54114 claims
PfizerEliquis$336$14,50512 claims
GSKAnoro Ellipta$172$11,65715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 878 medical providers in North Carolina.

Other medical in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →